Skip to content

A Study Investigating Properties of the Transversus Abdominis Plane Block

Transversus Abdominis Plane Block: A Placebo-controlled Study in Healthy Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01679392
Enrollment
16
Registered
2012-09-06
Start date
2012-08-31
Completion date
2013-05-31
Last updated
2015-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local

Keywords

Transversus abdominis plane block, Ultrasound guided nerve block

Brief summary

In this study we investigate the following properties of the transversus abdominis plane block in healthy volunteers: 1. Cutaneous analgesic distribution 2. Muscular affection 3. Reproducibility

Interventions

DRUGRopivacaine

Unilateral, single shot, ultrasound-guided, transversus abdominis plane block with 20 ml ropivacaine (7.5 mg/ml)

Sponsors

Hillerod Hospital, Denmark
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Capable * American society of anesthesiologists classification 1 or 2 * Written informed consent

Exclusion criteria

* Age below 18 years * American society of anesthesiologists classification above 2 * Body weight below 50 kg * Body mass index \> 35 kg/m2 * Previous abdominal surgery * Acute or chronic pain * Use of pain medication less than 24 h prior to study start * Allergy to local anesthetics * Pregnancy * Breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Cutaneous analgesic distribution90 minCutaneous analgesic distribution 90 min after transversus abdominis plane block administration

Secondary

MeasureTime frameDescription
Muscular affection of the transversus abdominis plane block90 minAbdominal wall muscle affection of the transversus abdominal plane block measured by ultrasonography under standardized conditions
Reproducibility of the transversus abdominis plane blockAt least 2 daysReproducibility of the transversus abdominis plane block with respect to: 1. Cutaneous analgesic distribution 2. Abdominal wall muscle affection measured in the same individual separated by at least 2 days

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026